Tiny study explores better lead placement for sleep apnea device

NCT ID NCT03985527

Completed Knowledge-focused Sponsor: Respicardia, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This small study tested whether placing a nerve stimulation lead in a different spot during a sleep apnea device implant could improve breathing. 29 adults with moderate to severe central sleep apnea took part. The goal was to see immediate changes in breathing and airway function, not long-term treatment effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: transvenous nerve stimulation device
What this could lead to: If successful, this could help refine how nerve stimulation devices are placed to better treat sleep apnea.
What could go wrong: This is a very small, early feasibility study with only 29 participants. It only measured immediate effects during the implant procedure, not long-term outcomes. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CENTRAL SLEEP APNEA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

central sleep apnea syndrome sleep apnea syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SLEEP APNEA SYNDROMES

Contacts and locations

Locations

Bryn Mawr Medical Specialists Association

Bryn Mawr, Pennsylvania, 19010, United States
Novant Health Forsyth Medical Center

Winston-Salem, North Carolina, 27013, United States
The Ohio State University Wexner Medical Center

Columbus, Ohio, 43210, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.